"Nov. 29, 2012 (Chicago) -- For cancer patients undergoing chemotherapy who have found their complaints of general mental fogginess and haziness dismissed by their doctors as not being a real medical condition, vindication has arrived.
Confusion, lethargy, and depression have been reported in a limited number of patients receiving continuous intravenous infusion of ZANOSAR for 5 days. Patients should be informed that there may be a potential risk in driving or using complex machinery.
Last reviewed on RxList: 2/2/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Zanosar Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.